Navigation Links
Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohn's Disease in the European Union
Date:3/7/2013

OSAKA, Japan, March 7, 2013 /PRNewswire/ --

Takeda Pharmaceutical Company Limited ("Takeda") today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EMA) for vedolizumab, an investigational, gut-selective humanized monoclonal antibody for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), the two most common types of inflammatory bowel disease (IBD). If approved, vedolizumab would be the first and only gut-selective biologic agent for UC and CD on the market.

"Ulcerative colitis and Crohn's disease are chronic debilitating diseases with important unmet medical needs, often affecting young people in the prime of their lives," said Asit Parikh , M.D., Ph.D., vice president, general medicine, Takeda. "We are encouraged by the findings of GEMINI, the vedolizumab Phase 3 clinical development program, which studied approximately 3,000 patients in nearly 40 countries, making it the largest IBD clinical trial program conducted to date."

Nearly four million people worldwide are affected by IBD, with UC affecting more than 500,000 people and CD affecting approximately 230,000 people in the EU.Crohn's disease and ulcerative colitis are chronic diseases that cause inflammation of the lining of the digestive tract. Inflammation caused by CD can involve varying areas of the digestive tract, while UC impacts the colon only.CD and UC can be both painful and debilitating, which may sometimes lead to serious complications and can significantly impact the quality of life for patients.

The MAA submission was supported by Phase 3 clinical studies, GEMINI I, GEMINI II, GEMINI III and GEMINI LTS (Long-term Safety), which are part of the GEMINI Studies™, a four-study clinical research program to investigate the efficacy and safety of vedolizumab on clinical response and remission
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
2. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
3. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
4. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
5. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
6. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
7. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
8. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
9. Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
10. Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
11. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... , Oct. 24, 2014  According to a survey ... MOSAIQ® Oncology Information System earned the number one ... KLAS, "Oncology 2014: Integration is Key" report. The survey ... has improved their MOSAIQ interfaces to take a commanding ... 100, 93 percent of customers said they would buy ...
(Date:10/25/2014)... , Oct. 24, 2014 Research ... "Dental Equipment Market Current Trends, Opportunities - Global Forecast ... In this report, the global dental equipment market ... The dental systems and equipment market is expected to ... market during the forecast period (2014 to 2019). This ...
(Date:10/25/2014)... , Oct. 24, 2014 Advanced Photonix ® ... September 26, 2014) financial results on Monday, November 10, 2014. ... after the close of the market and the Company will ... at 4:30 p.m. EDT on the same day. ... (CEO and Director), Rob Risser (COO and Director), ...
Breaking Medicine Technology:Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report 2Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report 3Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Advanced Photonix to Webcast Fiscal 2015 Second Quarter Earnings 2
... Pepto-Bismol announced today that for the second year in ... … PINK? In an act of true gastro-patriotism, Pepto-Bismol has ... Fourth of July International Hot Dog Eating Contest for the ... this contest a celebration to remember, Pepto-Bismol has enlisted the ...
... Hospira, Inc. (NYSE: HSP ), a leading ... it will host a conference call to discuss its second-quarter ... Central time.   The company will release its ... open and the conference call. A live ...
Cached Medicine Technology:Pepto-Bismol and Nick Cannon Heat Things up at this Year's Nathan's Famous Fourth of July International Hot Dog Eating Contest 2Pepto-Bismol and Nick Cannon Heat Things up at this Year's Nathan's Famous Fourth of July International Hot Dog Eating Contest 3
(Date:10/25/2014)... New York, New York (PRWEB) October 25, 2014 ... lawsuits ( http://www.thexareltolawsuit.com/ ) will be addressed in December, ... convenes its next hearing session. According to a Hearing ... Oral Arguments on the matter will be heard on ... Session will begin at 9:30 a.m. (In Re: Xarelto ...
(Date:10/25/2014)... 25, 2014 The global HCIT outsourcing ... 7.6%, to reach $50.4 billion by 2018 from $35 ... industry, and pharmaceutical industry are driving the HCIT outsourcing ... enhance their focus on core business, reduce operational and ... staff (further reducing hiring and training costs), share risk, ...
(Date:10/25/2014)... home safe and sound is one of the best Halloween ... costumes and goody bags have reflective strips that improve visibility ... at Meadowlands Hospital Medical Center in Secaucus, N.J. ... flame-resistant, Davis said. He offers these others tips: ... a small area of skin first to ensure it doesn,t ...
(Date:10/25/2014)... (PRWEB) October 25, 2014 More than ... President’s Circle Reception on Monday at the home of ... and hear from guest speaker Dr. Winifred Lender on ... , Dr. Lender, a Santa Barbara psychologist, author and ... and benefits of living in the digital age. Our ...
(Date:10/25/2014)... Background: , In 1998 Bob Savage founded the ... in the field of establishing recovery community organizations. Bob ... when he retired, he set out to answer a couple ... , 1. Where are the people in recovery ... 2. Can the recovery community be organized to advocate for ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 2Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 4Health News:Tips for Safe Trick-or-Treating 2Health News:Finding Balance between the Real & Digital World Topic of Family Service Agency Reception 2Health News:Finding Balance between the Real & Digital World Topic of Family Service Agency Reception 3Health News:Finding Balance between the Real & Digital World Topic of Family Service Agency Reception 4Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2
... is the case with most other developing countries, plastic bags have ... the situation seems to be spiraling out of control, the government ... ,In Uganda they are called buveera , and they ... up at an organized dump like the one at Chitezi in ...
... nonsmoking restaurant and bar employees absorb a potent carcinogennot ... where they had to breathe tobacco smoke from customers ... body only as a result of using tobacco or ... County Health Department and Oregon Department of Human Services ...
... New Delhi, The dry text of science books often despised ... cartoon characters. ,In its recently published science ... Research and Training (NCERT) has introduced two cartoon characters, 'Boojho' ... also on the lookout for answers. ,"Our aim ...
... common joint disorder worldwide, yet the cause of osteoarthritis of ... play a role is femoro-acetabular impingement (FAI), in which the ... on the hip socket (acetabulum). ,FAI caused by ... but it is not known if FAI that is not ...
... statisticians and economists were Saturday winding up four days of ... questions: what is happiness and how do you measure ... for Economic Cooperation and Development acknowledged that the indices used ... as national wealth and Gross Domestic Product, were no longer ...
... given Girls as young as 5 who suffer from cancer ... ,Doctors have extracted, matured and frozen eggs from girls ... up. ,Childhood cancers usually result in cure rates ... which is often needed can render children sterile. The life ...
Cached Medicine News:Health News:Uganda Bans Plastic Bags, Still a Tough Battle Lies Ahead 2Health News:Non Smoking Workers Absorb the Carcinogen Immediately 2Health News:Non Smoking Workers Absorb the Carcinogen Immediately 3Health News:Cartoons to Dispel Science Phobia for Students 2Health News:Osteoarthritis Facts and Causes 2Health News:Experts in Istanbul Seek Nature and Measure of Happiness 2Health News:Girls With Cancer Given Fertility Hope 2
... formulated buffers are available from ... antimony catheters. All buffers are ... internal or external reference, single ... are available in 250ml bottle ...
Flexilog custom medical carts are configured to suite the requirements of FLEXILOG motility system users. With locking wheels and storage drawers, our carts are suitable for any care provider in any ...
Bravo Tubing/Filter Supplies (Ten tubing sets, ten filters)...
... lower esophhageal sphincter (LES) can ... a separate manometry system. pH ... identification accessory kit and Digitrapper ... locate the LES. The kit ...
Medicine Products: